模拟慢性髓性白血病耐药的甲磺酸伊马替尼治疗依从性不佳 - Suppr

Suppr

超能文献

Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance.

作者信息

Sandoval Claudio, Giamelli Joseph, Jayabose Somasundaram

出版信息

J Pediatr Hematol Oncol. 2003 Jun;25(6):507-8. doi: 10.1097/00043426-200306000-00017.

DOI:10.1097/00043426-200306000-00017

PMID:12794534

Abstract

摘要

相似文献

Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance.

J Pediatr Hematol Oncol. 2003 Jun;25(6):507-8. doi: 10.1097/00043426-200306000-00017.

Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?

Leuk Lymphoma. 2008 Jun;49(6):1022-3. doi: 10.1080/10428190802074635.

New directions in the treatment of patients with chronic myeloid leukemia: introduction.

Semin Hematol. 2009 Apr;46(2 Suppl 3):S1-4. doi: 10.1053/j.seminhematol.2009.01.006.

Cross-resistance of imatinib mesylate and 17-AAG in imatinib-resistant cells that overexpress BCR-ABL.

Br J Haematol. 2003 May;121(4):672-3. doi: 10.1046/j.1365-2141.2003.04330.x.

Why doesn't imatinib cure chronic myeloid leukemia?

Oncologist. 2010;15(2):182-6. doi: 10.1634/theoncologist.2009-0297. Epub 2010 Feb 2.

[Current state and the future of molecular target drugs: lessons learned from the success of imatinib].

Nihon Yakurigaku Zasshi. 2008 Dec;132(6):339-42. doi: 10.1254/fpj.132.339.

STI-571 in chronic myelogenous leukaemia.

Br J Haematol. 2002 Oct;119(1):15-24. doi: 10.1046/j.1365-2141.2002.03899.x.

3. Imatinib therapy in chronic myelogenous leukemia.

Intern Med. 2007;46(2):95-7. doi: 10.2169/internalmedicine.46.1781. Epub 2007 Jan 15.

Chronic myeloid leukemia arising from acute myeloid leukemia: response to imatinib mesylate with favorable outcome.

Leuk Lymphoma. 2013 Jan;54(1):195-7. doi: 10.3109/10428194.2012.692788. Epub 2012 Jun 13.

Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate.

Int J Hematol. 2010 Oct;92(3):559-61. doi: 10.1007/s12185-010-0679-5. Epub 2010 Sep 14.

引用本文的文献

Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients.

Med Oncol. 2012 Jun;29(2):1179-85. doi: 10.1007/s12032-011-9926-8. Epub 2011 Apr 7.

Clinical pharmacokinetics of imatinib.

Clin Pharmacokinet. 2005;44(9):879-94. doi: 10.2165/00003088-200544090-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance.

J Pediatr Hematol Oncol. 2003 Jun;25(6):507-8. doi: 10.1097/00043426-200306000-00017.

Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?

Leuk Lymphoma. 2008 Jun;49(6):1022-3. doi: 10.1080/10428190802074635.

New directions in the treatment of patients with chronic myeloid leukemia: introduction.

Semin Hematol. 2009 Apr;46(2 Suppl 3):S1-4. doi: 10.1053/j.seminhematol.2009.01.006.

Cross-resistance of imatinib mesylate and 17-AAG in imatinib-resistant cells that overexpress BCR-ABL.

Br J Haematol. 2003 May;121(4):672-3. doi: 10.1046/j.1365-2141.2003.04330.x.

Why doesn't imatinib cure chronic myeloid leukemia?

Oncologist. 2010;15(2):182-6. doi: 10.1634/theoncologist.2009-0297. Epub 2010 Feb 2.

[Current state and the future of molecular target drugs: lessons learned from the success of imatinib].

Nihon Yakurigaku Zasshi. 2008 Dec;132(6):339-42. doi: 10.1254/fpj.132.339.

STI-571 in chronic myelogenous leukaemia.

Br J Haematol. 2002 Oct;119(1):15-24. doi: 10.1046/j.1365-2141.2002.03899.x.

3. Imatinib therapy in chronic myelogenous leukemia.

Intern Med. 2007;46(2):95-7. doi: 10.2169/internalmedicine.46.1781. Epub 2007 Jan 15.

Chronic myeloid leukemia arising from acute myeloid leukemia: response to imatinib mesylate with favorable outcome.

Leuk Lymphoma. 2013 Jan;54(1):195-7. doi: 10.3109/10428194.2012.692788. Epub 2012 Jun 13.

Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate.

Int J Hematol. 2010 Oct;92(3):559-61. doi: 10.1007/s12185-010-0679-5. Epub 2010 Sep 14.

引用本文的文献

Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients.

Med Oncol. 2012 Jun;29(2):1179-85. doi: 10.1007/s12032-011-9926-8. Epub 2011 Apr 7.

Clinical pharmacokinetics of imatinib.

Clin Pharmacokinet. 2005;44(9):879-94. doi: 10.2165/00003088-200544090-00001.